We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Magnetic Robot That Moves Through Arteries Could Revolutionize Stroke Treatment

By HospiMedica International staff writers
Posted on 16 Feb 2024

Ischemic stroke occurs when the blood supply to the brain is interrupted due to a blockage in blood vessels. More...

Now, a cutting-edge technology promises to revolutionize stroke treatment. Scientists have created a magnetically operated robot for the treatment of ischemic stroke that is small enough to navigate the complex network of tiny blood vessels in the human brain. The robot restores blood flow by drilling through the blockage material in the brain, helping improve the motor functions and overall recovery of stroke patients.

This robot developed at ETH Zurich (Zurich, Switzerland) is propelled by an external magnet, and features a soft tip to avoid damaging blood vessels. Its soft tip reduces the risk of vascular damage, prioritizing patient safety. The robot's primary role is to penetrate the material obstructing the brain's blood flow, thereby restoring normal circulation. A standout feature is its precision and ability to adapt to the complex vascular structure of the human brain. Operated by an external magnet, the robot can rotate and move forward in a controlled way, marking a significant advancement in stroke therapy that could greatly enhance patient outcomes.

The robot has undergone extensive testing for effectiveness and safety, including trials in silicone models that simulate human blood vessels, as well as experiments using a human placenta and a live pig to assess performance in living tissues. These tests have yielded promising results, indicating this technology's potential to revolutionize medical treatment. While not yet approved for human patient use, the researchers at ETH Zurich are optimistic about its future application in stroke treatment. They continue to focus on research and development, with high hopes for the robot's ability to improve the quality of life for stroke patients.

Related Links:
ETH Zurich


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Monitoring System
AlarmSense
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.